Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients

Xijing Hospital2,000 enrolled

Overview

The purpose of this observational study is to understand the impact of polypharmacy on the prognosis of elderly patients with chronic diseases. The main research question it aims to address is: Does polypharmacy affect the prognosis of elderly patients with chronic diseases? Elderly patients with chronic diseases will be asked to complete online survey questions regarding their disease prognosis over a 2-year period.

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

Coronary Artery Disease Diabete Mellitus Chronic Kidney Disease Hypertension Heart Failure Hyperlipidemia Obesity &Amp; Overweight Chronic Obstructive Pulmonary Disease (COPD)

Eligibility

Sex: ALLMin age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients aged 65 years or older with at least one chronic disease Exclusion Criteria: * Patients without chronic diseases * Patients refused to participate in the study * Patients with unstable vital signs

Outcomes

Primary Outcomes

Assessing the current status of polypharmacy in elderly patients with chronic diseases in Shaanxi Province via cluster sampling questionnaire survey

A cluster sampling method was used to conduct a survey on elderly patients with chronic diseases in Shaanxi Province. A questionnaire survey was conducted in different regional locations to collect detailed medication information from patients, such as the number of chronic diseases (types), the types of medications used (types), specific drug names, medication costs (yuan), and duration of medication use (months). Medication habits, such as whether the medication is prescribed by a hospital, purchased from a pharmacy, recommended by friends, or promoted through advertisements, etc. Specific items include concerns about drugs and current physical discomforts. A 5-point Likert scale was adopted, where 1 point indicates "strongly disagree" and 5 points indicate "strongly agree". After questionnaire collection, combined with Beers, STOPP/START, and Chinese elderly PIM criteria, a polypharmacy evaluation and management strategy for these patients was developed.

Time frame: Start from enrollment to the end of the study at 2 years.